MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1
- PMID: 23001043
- DOI: 10.1038/onc.2012.432
MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1
Abstract
MicroRNAs have key roles in tumor metastasis. Here, we describe the regulation and function of miR-34a and miR-34c (miR-34a/c) in breast cancer metastasis. Expression analysis verified that miR-34a/c expression is significantly decreased in metastatic breast cancer cells and human primary breast tumors with lymph node metastases. Overexpression of miR-34a/c could inhibit breast cancer cell migration and invasion in vitro and distal pulmonary metastasis in vivo. Further studies revealed that Fos-related antigen 1 (Fra-1 or Fosl1) is a downstream target of miR-34a/c as miR-34a/c bound directly to the 3'untranslated region of Fra-1, subsequently reducing both the mRNA and protein levels of Fra-1. Silencing of Fra-1 recapitulated the effects of miR-34a/c overexpression, whereas enforced expression of Fra-1 reverses the suppressive effects of miR-34a/c. Moreover, significant downregulation of miR-34a in metastatic breast cancer tissues was found to be inversely correlated with Fra-1 expression. Our results demonstrate that miR-34a/c functions as a metastasis suppressor to regulate breast cancer migration and invasion through targeting Fra-1 oncogene and suggest a therapeutic application of miR-34 in breast cancer.
Similar articles
-
MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.Carcinogenesis. 2012 Mar;33(3):519-28. doi: 10.1093/carcin/bgr304. Epub 2011 Dec 22. Carcinogenesis. 2012. PMID: 22198213
-
A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.Cancer Res. 2014 Jul 15;74(14):3764-78. doi: 10.1158/0008-5472.CAN-13-3555. Epub 2014 Jun 6. Cancer Res. 2014. PMID: 24906624
-
MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers.Oncogene. 2012 Oct 18;31(42):4509-16. doi: 10.1038/onc.2011.581. Epub 2011 Dec 19. Oncogene. 2012. PMID: 22179828
-
Expanding the Biotherapeutics Realm via miR-34a: "Potent Clever Little" Agent in Breast Cancer Therapy.Curr Pharm Biotechnol. 2019;20(8):665-673. doi: 10.2174/1389201020666190617162042. Curr Pharm Biotechnol. 2019. PMID: 31244419 Review.
-
FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer.Int J Mol Sci. 2023 May 5;24(9):8307. doi: 10.3390/ijms24098307. Int J Mol Sci. 2023. PMID: 37176013 Free PMC article. Review.
Cited by
-
MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer.Theranostics. 2015 Jul 13;5(10):1122-43. doi: 10.7150/thno.11543. eCollection 2015. Theranostics. 2015. PMID: 26199650 Free PMC article. Review.
-
Proteotranscriptomic Profiling of 231-BR Breast Cancer Cells: Identification of Potential Biomarkers and Therapeutic Targets for Brain Metastasis.Mol Cell Proteomics. 2015 Sep;14(9):2316-30. doi: 10.1074/mcp.M114.046110. Epub 2015 Jun 3. Mol Cell Proteomics. 2015. PMID: 26041846 Free PMC article.
-
Epigenetic alterations involved in cancer stem cell reprogramming.Mol Oncol. 2012 Dec;6(6):620-36. doi: 10.1016/j.molonc.2012.10.006. Epub 2012 Oct 26. Mol Oncol. 2012. PMID: 23141800 Free PMC article. Review.
-
MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET.Cell Death Dis. 2015 Jan 22;6(1):e1618. doi: 10.1038/cddis.2014.582. Cell Death Dis. 2015. PMID: 25611392 Free PMC article.
-
Upregulation of miR-34a-5p, miR-20a-3p and miR-29a-3p by Onconase in A375 Melanoma Cells Correlates with the Downregulation of Specific Onco-Proteins.Int J Mol Sci. 2022 Jan 31;23(3):1647. doi: 10.3390/ijms23031647. Int J Mol Sci. 2022. PMID: 35163570 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical